Karachi: AGP Limited has announced that a meeting of its Board of Directors will take place on October 29, 2024, to discuss the financial statements for the quarter ending September 30. The meeting, scheduled at Karachi, will also be accessible via video facility to accommodate all directors.

The focus of the meeting will be to review the company's financial performance for the recent quarter and to decide on any resultant declarations of entitlements. According to information available from the Pakistan Stock Exchange (PSX), AGP Limited has also instituted a "Closed Period" starting October 22, 2024, until the day of the board meeting on October 29, 2024. During this period, no director, CEO, or executive shall engage in trading of the company’s shares.

This closed period is in compliance with Clause 5.6.4 of PSX Regulations, which mandates such a restriction to prevent any potential misuse of unpublished financial information. The company has advised informing TRE Certificate Holders of this development to ensure compliance with regulatory requirements.

AGP Limited, headquartered in Karachi and listed under the Pakistan Stock Exchange, is a known entity in the pharmaceutical sector, focusing on innovations and value to life.